SOURCE: BASi (Bioanalytical Systems, Inc.)

June 24, 2008 10:00 ET

BASi-Swiftwater Group Alliance Expands Contract Services

WEST LAFAYETTE, IN and TUCSON, AZ--(Marketwire - June 24, 2008) - BASi (Bioanalytical Systems, Inc.) (NASDAQ: BASI) and Swiftwater Group, LLC today announced their agreement to form an alliance that will complement and expand both firms' service offerings.

Swiftwater Group brings its extensive product development, regulatory, project management and auditing experience to work with BASi's contract research services for the pharmaceutical industry. BASi will offer a preferred provider arrangement for Swiftwater Group clients, and BASi clients will have access to Swiftwater Group's consultancy services that will allow clients a single point of contact for a broad spectrum of services.

About Swiftwater Group, LLC

Swiftwater Group contributes a blend of scientific and drug development experience, focusing on non-clinical and clinical development planning, regulatory submissions and communication, protocol preparation, and clinical program management including QA/QC audits and site monitoring. For more information see

About BASi

BASi provides contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking new drugs to market. Visit for more about BASi.

Contact Information